Latest News Archive
Please select Category, Year, and then Month to display items
21 November 2024
|
Story Jacky Tshokwe
|
Photo Supplied
Prof Mogomme Masoga, Dean: Faculty of the Humanities.
On 8 November 2024, the South African Humanities Deans Association (SAHUDA) elected Prof Mogomme Masoga, Dean of the Faculty of The Humanities at the University of the Free State (UFS), as its new President. This appointment marks a pivotal moment for SAHUDA, which represents a diverse network of deans who champion the prominence and future of humanities, social sciences, and the arts in South Africa and beyond. Prof Masoga, who has served as Vice-President of SAHUDA for the past year, brings a wealth of experience and a deep commitment to advocating for the role of humanities in addressing the challenges of our contemporary world.
As President, Prof Masoga envisions broadening the influence of what he terms ‘public and applied humanities.’ His aim is to advance a humanities framework that not only enriches academic discourse, but also engages with critical global and local issues. This approach, rooted in socially responsive scholarship, will prioritise areas such as computational and digital humanities, environmental humanities, and other interdisciplinary fields that intersect with the pressing concerns of our time.
“The humanities are more relevant than ever to understanding complex societal issues,” Prof Masoga explained. “Through public and applied humanities, we can bring the critical perspectives of our field into active dialogue with the challenges of a digital and ecologically threatened world.”
His election underscores the University of the Free State's growing influence in national and international conversations about the future of the humanities. For the UFS, this leadership role enhances its reputation as an institution deeply invested in fostering meaningful contributions to society. Prof Masoga’s presidency is set to amplify the university’s voice and perspectives in SAHUDA’s mission to fortify the role of humanities in education and public life.
Over the next two years, Prof Masoga’s tenure will include a focus on initiatives that strengthen the relevance of humanities scholarship, encourage interdisciplinary research, and cultivate public engagement. He will also prioritise fostering collaboration across higher education institutions in South Africa and internationally to ensure that humanities disciplines are equipped to address the diverse needs of our rapidly evolving world.
Prof Masoga’s commitment to SAHUDA’s mission reflects the values and aspirations of the UFS Faculty of The Humanities. His presidency is an invaluable opportunity for the university to contribute to the national agenda of reinforcing the humanities as a field essential to a healthy, critically informed, and culturally aware society. This achievement serves as a proud moment for the UFS and a beacon for the potential of the humanities to drive societal progress in South Africa and beyond.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004